CDH17 and familial pancreatic carcinoma: We demonstrated that the biohybrid bacteria (Nb289‐MG1655‐CR) specifically accumulated in CDH17‐positive tumors, including fibrotic pancreatic cancer, and significantly inhibited tumor growth without evident side effects after a single administration and one‐time irradiation (Figures 4 and 6).